Delcath Systems Inc (DCTH)

[SharonB]

Daily updated chart..http://stockcharts.com/h-sc/ui?c=dcth,uu[h,a]daclyyay[pb50!b200!f][vc60][iut!ub14!la12,26....
Copy entire link and paste into your browser.

SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?company=&CIK=dcth&filenum=&State=&SIC=&owner=include&action=getcompany

Press Releases
http://www.delcath.com/newsroom.shtml

November 29, 2007
Delcath Granted Japanese Patent for Delcath System

November 20, 2007
Delcath Resumes Enrollment in Phase III and Phase II Trials

October 23, 2007
Delcath Voluntarily Defers Accrual in Clinical Trials

October 18, 2007


Delcath Systems Technology Profiled in European Medical Technology Publication

October 11, 2007
Delcath Treatment for Liver Cancer is 'Featured Clinical Trial' in Latest National Cancer Institute (NCI) Cancer Bulletin

October 4, 2007
Delcath Systems Issues CEO Letter to Shareholders

September 26, 2007
Delcath Announces Closing of $14.2 Million Investment by Institutional Investors Proceeds To Fund Completion of Phase III Trial for the Treatment of Liver Cancer

September 24, 2007
Delcath to Present at the 12th Annual Drug Delivery Technologies
& Deal Making Conference

September 18, 2007
Delcath Systems, Inc. Raises $14.2 Million in Private Offering

September 18, 2007
Delcath to Present at the CL King Best Ideas Conference

September 17, 2007
Delcath to Present at the ThinkEquity Partners' 5th Annual Growth Conference

August 20, 2007
SAMUEL HERSCHKOWITZ, M.D. RESIGNS AS DIRECTOR OF DELCATH

August 2, 2007
Delcath to Present at the Canaccord Adams Global Growth Conference

July 27, 2007
Delcath to Present at the ThinkBIG
2007 Conference Sponsored by ThinkEquity Partners LLC


June 28, 2007
DELCATH TO PRESENT AT THE THIRD ANNUAL
C.E. UNTERBERG, TOWBIN EMERGING GROWTH CONFERENCE

June 26, 2007
Delcath Expands Phase II Multi-Histology Clinical Trial
New Arm to Treat Relapsed Melanoma Patients Previously Shown to Respond to Isolated Hepatic Perfusion


June 13, 2007
Delcath Fulfills Nasdaq Independent Director and Audit Committee Requirements With Addition of Two New Directors

June 5, 2007
Delcath Updates Clinical Trials

June 5, 2007
Jonathan J. Lewis, MD Joins Delcath's Board of Directors

May 30, 2007
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Center

May 24, 2007
Delcath Systems Names Laura A. Philips to Board of Directors

May 24, 2007
Delcath Systems Adds Two Executives

May 17, 2007
Delcath Systems Announces Presentation of Data at World Conference on Interventional Oncology

May 16, 2007
Delcath Systems Issues CEO Letter to Shareholders

May 10, 2007
DELCATH SYSTEMS FILES FIRST QUARTER 2007 10-Q AND SHELF REGISTRATION

April 17, 2007
Delcath Systems Announces Board Resignations

April 10, 2007
DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN

March 29, 2007
Delcath Systems Extends Cooperative Research And Development Agreement With The National Cancer Institute

February 26, 2007
Delcath Systems Reports Positive Data From Ongoing Phase II Multi-Histology Trial at the Second International Symposium on Regional Cancer Therapies

February 20, 2007
Delcath Systems to Host Conference Call & Webcast For Investors

February 15, 2007
Delcath Systems Co-Sponsors Second International Symposium On Regional Cancer Therapies

February 9, 2007
Delcath Systems Retains Former Director of Operations as Advisor

February 2, 2007
Delcath Elects Dr. Harold Koplewicz Chairman of the Board of Directors
Delcath Settles Litigation Against Former Director of Operations

January 26, 2007
Delcath Announces the Resignation of M. S. Koly as Chairman of the Board of Directors

January 4, 2007
Delcath Appoints Dr. Samuel Herschkowitz as Interim COO

SharonB